Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating) – Zacks Research issued their Q1 2023 earnings per share (EPS) estimates for Cardiovascular Systems in a research report issued on Wednesday, September 28th. Zacks Research analyst D. Dey anticipates that the medical device company will post earnings of ($0.22) per share for the quarter. The consensus estimate for Cardiovascular Systems' current full-year earnings is ($0.67) per share. Zacks Research also issued estimates for Cardiovascular Systems' Q2 2023 earnings at ($0.16) EPS, Q3 2023 earnings at ($0.15) EPS, Q4 2023 earnings at ($0.15) EPS, FY2023 earnings at ($0.68) EPS, Q1 2024 earnings at ($0.18) EPS, Q2 2024 earnings at ($0.11) EPS, Q3 2024 earnings at ($0.18) EPS, Q4 2024 earnings at ($0.07) EPS, FY2024 earnings at ($0.53) EPS and FY2025 earnings at ($0.49) EPS.
Get Cardiovascular Systems alerts:Cardiovascular Systems Trading Down 1.1 %
Shares of CSII stock opened at $13.86 on Monday. The company has a quick ratio of 5.19, a current ratio of 6.05 and a debt-to-equity ratio of 0.08. The business has a 50-day moving average price of $14.72 and a two-hundred day moving average price of $16.46. Cardiovascular Systems has a 12-month low of $12.51 and a 12-month high of $36.97. The firm has a market cap of $567.77 million, a P/E ratio of -14.59 and a beta of 0.97.
Cardiovascular Systems (NASDAQ:CSII – Get Rating) last issued its quarterly earnings results on Tuesday, August 2nd. The medical device company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by ($0.03). Cardiovascular Systems had a negative return on equity of 14.40% and a negative net margin of 15.64%. The firm had revenue of $62.50 million for the quarter, compared to the consensus estimate of $62.88 million.Institutional Investors Weigh In On Cardiovascular Systems
Several hedge funds have recently added to or reduced their stakes in the company. Rhumbline Advisers lifted its stake in Cardiovascular Systems by 0.6% during the fourth quarter. Rhumbline Advisers now owns 99,634 shares of the medical device company's stock worth $1,871,000 after purchasing an additional 566 shares during the last quarter. UBS Group AG lifted its stake in shares of Cardiovascular Systems by 6.3% in the 2nd quarter. UBS Group AG now owns 11,500 shares of the medical device company's stock valued at $165,000 after acquiring an additional 679 shares during the last quarter. PNC Financial Services Group Inc. lifted its stake in shares of Cardiovascular Systems by 32.1% in the 1st quarter. PNC Financial Services Group Inc. now owns 3,025 shares of the medical device company's stock valued at $68,000 after acquiring an additional 735 shares during the last quarter. Eaton Vance Management lifted its stake in shares of Cardiovascular Systems by 5.4% in the 4th quarter. Eaton Vance Management now owns 14,547 shares of the medical device company's stock valued at $252,000 after acquiring an additional 749 shares during the last quarter. Finally, Perkins Capital Management Inc. lifted its stake in shares of Cardiovascular Systems by 3.1% in the 2nd quarter. Perkins Capital Management Inc. now owns 25,200 shares of the medical device company's stock valued at $362,000 after acquiring an additional 750 shares during the last quarter. Institutional investors own 91.72% of the company's stock.
Cardiovascular Systems Company Profile
(Get Rating)
Cardiovascular Systems, Inc, a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.
Recommended Stories
- Get a free copy of the StockNews.com research report on Cardiovascular Systems (CSII)
- Archer Daniels Midland: Dividend Hero With 49 Years Of Increases
- Will Fully Autonomous Tractors Make Deere the Tesla of Farming?
- Magna International is Your Auto and EV One-Stop Shop Stock
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.